J&J ordered to pay $417 million in trial over talc cancer risks
Reuters: Health News
(Reuters) - A California jury on Monday ordered Johnson & Johnson to pay $417 million to a woman who claimed she developed ovarian cancer after using the company's talc-based products like Johnson's Baby Powder for feminine hygiene.
(Reuters Health) - Few smokers hospitalized for heart attacks and other serious complications of cardiac disease get medication to help them quit smoking, a U.S. study suggests.
(Reuters Health) - Fewer than half of U.S. infants always sleep on their backs, the position doctors recommend to avoid sleep-related injuries and deaths, a study suggests.
(Reuters) - ASL Strategic Value Fund has sought the replacement of hospital operator Community Health Systems Inc's chief executive, Wayne Smith.
BRUSSELS (Reuters) - Belgian biscuit maker Lotus Bakeries said it had recalled some of its products in Belgium as they could contain eggs that were contaminated with insecticide fipronil.
LONDON (Reuters) - Pharmaceutical company Shire said its chief financial officer Jeff Poulton will stand down at the end of the year to join Indigo Ag, a Boston-based start-up that seeks to improve agricultural productivity.
NYT > Health
Harklinikken, a Danish company with an extract to fight hair loss, has come to the United States, where it is aggressively opening clinics.
ABC News: Health
The attorney for a hospitalized woman who won a $417 million judgment in a lawsuit claiming the talc in Johnson & Johnson's iconic baby powder causes ovarian cancer says his client is not looking for sympathy
No comments:
Post a Comment